Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Dartmouth College · Rigshospitalet · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
732
total citations
- FWCI
- 49.74
- Percentile
- 100%
- References
- 38
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Migraine
- Placebo
- Medicine
- Double blind
- Physical therapy
- Clinical trial
- Alternative medicine
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.